Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein

Breast Cancer Research and Treatment

Volumn 135, Issue 3, 2012, Pages 749-758

  Goddio, M Victoria ^a   Gattelli, Albana ^a   Slomiansky, Victoria ^a   Lacunza, Ezequiel ^b   Gingerich, Timothy ^c   Tocci, Johanna M ^a   Facchinetti, María M ^d   Curino, Alejandro C ^d   LaMarre, Jonathan ^c   Abba, Martín C ^b   Kordon, Edith C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^c UNIVERSITY OF GUELPH   (Canada)

^d Instituto de Investigaciones Bioquimicas Bahia Blanca   (Argentina)

Author keywords

Breast cancer; Lactation; Mammary gland; Prolactin; Tristetraprolin

Indexed keywords

MESSENGER RNA; PROLACTIN; RNA BINDING PROTEIN; STAT5A PROTEIN; TRISTETRAPROLIN;

3' UNTRANSLATED REGION; ANIMAL TISSUE; ARTICLE; AU RICH ELEMENT; BREAST CANCER; BREAST CARCINOMA; BREAST CELL; BREAST LESION; BREAST TUMOR; CANCER CELL; CANCER GRADING; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LACTATION; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION; TISSUE DIFFERENTIATION;

ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LACTATION; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PREGNANCY; PROLACTIN; STAT5 TRANSCRIPTION FACTOR; TRISTETRAPROLIN; TUMOR SUPPRESSOR PROTEINS;

EID: 84866534415     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2216-0     Document Type: Article

References (39)

1. Chen CYA, Shyu AB (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20: 465-470
2. Guhaniyogi J, Brewer G (2001) Regulation of mRNA stability in mammalian cells. Gene 265:11-23 (Pubitemid 32209246)
3. Barreau C, Paillard L, Osborne HB (2005) AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 33:7138-7150 (Pubitemid 43125082)
4. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel D, Schenkman DI, Gilkeson GS, Broxmeyer HE, Haynes BF, Blackshear PJ (1996) A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4:445-454 (Pubitemid 26354654)
5. Smoak K, Cidlowski JA (2006) Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling. Mol Cell Biol 26:9126-9135 (Pubitemid 44851967)
6. Ishmael FT, Fang X, Galdiero MR, Atasoy U, Rigby WF, Gorospe M, Cheadle C, Stellato C (2008) Role of the RNAbinding protein tristetraprolin in glucocorticoid-mediated gene regulation. J Immunol 180:8342-8353
7. Brennan S, Kuwano Y, Alkharouf N, Blackshear PJ, Gorospe M, Wilson GM (2009) The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res 69:5168-5176
8. Griseri P, Bourcier C, Hieblot C, Essafi-Benkhadir K, Chamorey E, Touriol C, Pagès G (2011) A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. Hum Mol Genet 20: 4556-4568
9. Al-Souhibani N, Al-Ahmadi W, Hesketh JE, Blackshear PJ, Khabar KSA (2010) The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes. Oncogene 29:1-11
10. Reichardt HM, Horsch K, Grone HJ, Kolbus A, Beug H, Hynes N, Schütz G (2001) Mammary gland development and lactation are controlled by different glucocorticoid receptor activities. Eur J Endocrinol 145:519-527 (Pubitemid 32927082)
11. Strange R, Li F, Saurer S, Burkhardt A, Friis RR (1992) Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development 115:49-58
12. Pensa S, Watson CJ, Poli V (2009) Stat3 and the inflammation/ acute phase response in involution and breast cancer. J Mammary Gland Biol Neoplasia 14:121-129
13. Lyons TR, Schedin PJ, Borges VF (2009) Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia 14:87-98
14. Streuli CH (1993) Extracellular matrix and gene expression in mammary epithelium. Semin Cell Biol 4:203-212
15. Lin CQ, Bissell MJ (1993) Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J 7:737-743 (Pubitemid 23199531)
16. Danielson KG, Oborn CJ, Durban EM, Butel JS, Medina D (1984) Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc Natl Acad Sci USA 81:3756-3760 (Pubitemid 14087797)
17. Chammas R, Taverna D, Cella N, Santos C, Hynes NE (1994) Laminin and tenascin assembly and expression regulate HC11 mouse mammary cell differentiation. J Cell Sci 107:1031-1040 (Pubitemid 24119360)
18. van de Vijver MJ, He YD, Van't Veer LJ, Dai H, Hart AAM, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009 (Pubitemid 35461656)
19. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, van't Veer LJ, Perou CM (2006) Concordance among geneexpression-based predictors for breast cancer. N Engl J Med 355:560-569 (Pubitemid 44200649)
20. Abba MC, Sun H, Hawkins KA, Drake JA, Hu Y, Nunez MI, Gaddis S, Shi T, Horvath S, Sahin A, Aldaz CM (2007) Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status. Mol Cancer Res 5:881-890 (Pubitemid 47416665)
21. Anderson SM, Rudolph MC, McManaman JL, Neville MC (2007) Key stages in mammary gland development. Secretory activation in the mammary gland: it's not just about milk protein synthesis! Breast Cancer Res 9:204
22. Curino AC, Engelholm LH, Yamada SS, Holmbeck K, Lund RL, Molinolo AA, Behrendt N, Boye SN, Bugge TH (2005) Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy. J Cell Biol 169(6):977-985 (Pubitemid 41002873)
23. Buggiano V, Schere-Levy C, Gattelli A, Cirio MC, Marfil M, Nepomnaschy I, Piazzon I, Helguero L, Vanzulli S, Kordon E (2002) Origin and progression of pregnancy-dependent mammary tumors induced by new mouse mammary tumor virus variants. Breast Can Res Treat 75:191-202 (Pubitemid 35026112)
24. Dexter DL, Kowalski HM, Blazar BA, Fligiel Z, Vogel R, Heppner GH (1978) Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 38:3174-3181 (Pubitemid 9031291)
25. Beuvink I, Hess D, Flotow H, Hofsteenge J, Groner B, Hynes NE (2000) Stat5a serine phosphorylation. Serine 779 is constitutively phosphorylated in the mammary gland, and serine 725 phosphorylation influences prolactin-stimulated in vitro DNA binding activity. J Biol Chem 275:10247-10255 (Pubitemid 30202081)
26. Moriggl R, Gouilleux-Gruart V, Jahne R, Berchtold S, Gartmann C, Liu X, Hennighausen L, Sotiropoulos A, Groner B, Gouilleux F (1996) Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol Cell Biol 16:5691-5700 (Pubitemid 26315089)
27. Bertucci PY, Quaglino A, Pozzi AG, Kordon EC, Pecci A (2010) Glucocorticoid-induced impairment of mammary gland involution is associated with STAT5 and STAT3 signaling modulation. Endocrinology 151:5730-5740
28. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874 (Pubitemid 32878711)
29. Lonning PE, Sorlie T, Perou CM, Brown PO, Botstein D, Borresen-Dale A-L (2001) Microarrays in primary breast cancer-lessons from chemotherapy studies. Endocr Relat Cancer 8: 259-263 (Pubitemid 32947648)
30. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403-410
31. Ormandy CJ, Naylor M, Harris J, Robertson F, Horseman ND, Lindeman GJ (2003) Investigation of the transcriptional changes underlying functional defects in the mammary glands of prolactin receptor knockout mice. Recent Prog Horm Res 58:297-323 (Pubitemid 37339315)
32. Watson CJ, Burdon TG (1996) Prolactin signal transduction mechanisms in the mammary gland: the role of the Jak/Stat pathway. Rev Reprod 1:1-5
33. Barnstein BO, Li G, Wang Z, Kennedy S, Chalfant C, Nakajima H, Bunting KD, Ryan JJ (2006) Stat5 expression is required for IgE-mediated mast cell function. J Immunology 177:3421-3426 (Pubitemid 44277863)
34. Suzuki K, Nakajima H, Ikeda K, Maezawa Y, Suto A, Takatori H, Saito Y, Iwamoto I (2003) IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-alpha production in mast cells. J Exp Med 198:1717-1727 (Pubitemid 37494164)
35. Joe Y, Kim HJ, Kim S, Chung J, Ko MS, Lee WH, Chang KC, Park JW, Chung HT (2011) Tristetraprolin mediates antiinflammatory effects of nicotine in lipopolysaccharide-stimulated macrophages. J Biol Chem 286:24735-24742
36. DuBois RN, McLane MW, Ryder K, Lau LF, Nathans D (1990) A growth factor-inducible nuclear protein with a novel cysteine/ histidine repetitive sequence. J Biol Chem 265:19185-19191
37. Lai WS, Stumpo DJ, Blackshear PJ (1990) Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J Biol Chem 265:16556-16563
38. Mittelstadt PR, DeFranco A (2003) Induction of early response genes by cross-linking membrane Ig on B lymphocytes. J Immunol 150:4822-4832
39. Ogawa K, Chen F, Kim YJ, Chen Y (2003) Transcriptional regulation of tristetraprolin by transforming growth factor-beta in human T cells. J Biol Chem 278:30373-30381 (Pubitemid 36962432)